These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36354295)

  • 41. Validation of the Nanjing Criteria for Diagnosing Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstruction Syndrome.
    Zhang W; Liu L; Zhang M; Zhang F; Peng C; Zhang B; Chen J; Li L; He J; Xiao J; Feng Y; Wang X; Xiong A; Yang L; Zou X; Yu Y; Zhuge Y
    J Clin Transl Hepatol; 2021 Jun; 9(3):345-352. PubMed ID: 34221920
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Study of PA-HSOS severity grading to predict the prognosis of patients with PA-HSOS treated by transjugular intrahepatic portosystemic shunt].
    Chen YR; Zhang W; Zhang M; Zhang F; Xiao JQ; Yin Q; Zhuge YZ
    Zhonghua Gan Zang Bing Za Zhi; 2021 Jan; 29(1):46-53. PubMed ID: 33541023
    [No Abstract]   [Full Text] [Related]  

  • 43. Timing and efficacy of transjugular intrahepatic portosystemic shunt in patients with pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome.
    Wu F; Yu J; Gan H; Zhang H; Tian D; Zheng D
    Sci Rep; 2021 Nov; 11(1):21743. PubMed ID: 34741082
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical characteristics and treatment of pyrrolizidine alkaloid-related hepatic vein occlusive disease.
    Zhuge YZ; Wang Y; Zhang F; Zhu CK; Zhang W; Zhang M; He Q; Yang J; He J; Chen J; Zou XP
    Liver Int; 2018 Oct; 38(10):1867-1874. PubMed ID: 29297975
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The long persistence of pyrrolizidine alkaloid-derived pyrrole-protein adducts in vivo: Kinetic study following multiple exposures of a pyrrolizidine alkaloid containing extract of Gynura japonica.
    Chen Y; Xiong F; Wang W; Jiang K; Ye X; Deng G; Wang C; Yang L; Xiong A; Wang Z
    Toxicol Lett; 2020 May; 323():41-47. PubMed ID: 31982501
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk factors of poor prognosis in patients with pyrrolidine alkaloid-induced hepatic sinusoidal obstruction syndrome after transjugular intrahepatic portosystemic shunt.
    Xiao J; Tu J; Zhang H; Zhang F; Zhang W; Xu H; Yin Q; Yang J; Han H; Wang Y; Zhang B; Peng C; Zou X; Zhang M; Zhuge Y
    Hepatol Int; 2021 Jun; 15(3):720-729. PubMed ID: 33507485
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transjugular intrahepatic portosystemic shunt for pyrrolizidine alkaloid-related hepatic sinusoidal obstruction syndrome.
    Zhou CZ; Wang RF; Lv WF; Fu YQ; Cheng DL; Zhu YJ; Hou CL; Ye XJ
    World J Gastroenterol; 2020 Jun; 26(24):3472-3483. PubMed ID: 32655270
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lung injury induced by pyrrolizidine alkaloids depends on metabolism by hepatic cytochrome P450s and blood transport of reactive metabolites.
    He Y; Lian W; Ding L; Fan X; Ma J; Zhang QY; Ding X; Lin G
    Arch Toxicol; 2021 Jan; 95(1):103-116. PubMed ID: 33033841
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Blood microRNA Signatures Serve as Potential Diagnostic Biomarkers for Hepatic Sinusoidal Obstruction Syndrome Caused by
    Wang X; Zhang W; Yang Y; Chen Y; Zhuge Y; Xiong A; Yang L; Wang Z
    Front Pharmacol; 2021; 12():627126. PubMed ID: 33679405
    [No Abstract]   [Full Text] [Related]  

  • 50. Quercetin and baicalein suppress monocrotaline-induced hepatic sinusoidal obstruction syndrome in rats.
    Zhang J; Sheng Y; Shi L; Zheng Z; Chen M; Lu B; Ji L
    Eur J Pharmacol; 2017 Jan; 795():160-168. PubMed ID: 27979702
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Research progress of hepatic sinusoidal obstruction syndrome].
    Ke ZL; Liu YL
    Zhonghua Gan Zang Bing Za Zhi; 2022 Dec; 30(12):1298-1303. PubMed ID: 36891716
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatic regeneration is decreased in a rat model of sinusoidal obstruction syndrome.
    Schiffer E; Frossard JL; Rubbia-Brandt L; Mentha G; Pastor CM
    J Surg Oncol; 2009 Jun; 99(7):439-46. PubMed ID: 19353590
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytotoxicity of pyrrolizidine alkaloid in human hepatic parenchymal and sinusoidal endothelial cells: Firm evidence for the reactive metabolites mediated pyrrolizidine alkaloid-induced hepatotoxicity.
    Yang M; Ruan J; Fu PP; Lin G
    Chem Biol Interact; 2016 Jan; 243():119-26. PubMed ID: 26365561
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Retrorsine Cooperates with Gut Microbiota to Promote Hepatic Sinusoidal Obstruction Syndrome by Disrupting the Gut Barrier.
    Xiao L; Hu L; Chu H; Chen L; Yan J; Wang W; Yang X; Zhu Q; Du F; Song Y; Chen P; Hou X; Yang L
    J Clin Transl Hepatol; 2022 Dec; 10(6):1086-1098. PubMed ID: 36381109
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anticoagulant therapy likely increases risk of bleeding in Gynura segetum-induced hepatic sinus obstruction syndrome.
    Tan Y; Zhou X
    Medicine (Baltimore); 2024 Feb; 103(6):e35914. PubMed ID: 38335400
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thymosin β4 Exerts a Cytoprotective Function and Attenuates Liver Injury in Murine Hepatic Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation.
    Wang X; Zhou Y; Sun Q; Zhang Q; Zhou H; Zhang J; Du Y; Wang Y; Yuan K; Xu L; Zhang M; Yan D; Zeng L; Xu K; Sang W
    Transplant Cell Ther; 2023 Aug; 29(8):492.e1-492.e10. PubMed ID: 37192732
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatic sinusoidal obstruction syndrome caused by herbal medicine: CT and MRI features.
    Zhou H; Wang YX; Lou HY; Xu XJ; Zhang MM
    Korean J Radiol; 2014; 15(2):218-25. PubMed ID: 24643319
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Magnetic Resonance Imaging Findings in Patients With Pyrrolizidine Alkaloid-Induced Hepatic Sinusoidal Obstruction Syndrome.
    Li X; Yang X; Xu D; Li Q; Kong X; Lu Z; Bai T; Xu K; Ye J; Song Y
    Clin Gastroenterol Hepatol; 2017 Jun; 15(6):955-957. PubMed ID: 28126425
    [No Abstract]   [Full Text] [Related]  

  • 59. Tu-San-Qi (Gynura japonica): the culprit behind pyrrolizidine alkaloid-induced liver injury in China.
    Zhu L; Zhang CY; Li DP; Chen HB; Ma J; Gao H; Ye Y; Wang JY; Fu PP; Lin G
    Acta Pharmacol Sin; 2021 Aug; 42(8):1212-1222. PubMed ID: 33154553
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression profiles of lncRNAs and their possible regulatory role in monocrotaline-induced HSOS in rats.
    Ismail M; Zhang X; Taha R; Elhafiz M; Zhang Q; Yousef BA; Huang X; Jiang Z; Zhang L; Sun L
    Front Genet; 2023; 14():1041266. PubMed ID: 36777738
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.